111 related articles for article (PubMed ID: 6359372)
1. Identification of an anti-human osteogenic sarcoma monoclonal-antibody-defined antigen on mitogen-stimulated peripheral blood mononuclear cells.
Price MR; Campbell DG; Baldwin RW
Scand J Immunol; 1983 Nov; 18(5):411-20. PubMed ID: 6359372
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of the cell surface antigen, p72, associated with a variety of human tumours and mitogen-stimulated T-lymphoblasts.
Price MR; Campbell DG; Robins RA; Blecher TE; Baldwin RW
FEBS Lett; 1984 Jun; 171(1):31-5. PubMed ID: 6609840
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of a cell surface antigen defined by an anti-human osteogenic sarcoma monoclonal antibody.
Price MR; Campbell DG; Robins RA; Baldwin RW
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):81-90. PubMed ID: 6343092
[TBL] [Abstract][Full Text] [Related]
4. Differentiation between monoclonal antibody-defined antigens on a human osteogenic sarcoma cell line (791T) and tumor-localizing properties of the anti-791T/36 antibody.
Dawood F; Embleton MJ; Price MR; Pimm MV; Byers VS; Baldwin RW
Braz J Med Biol Res; 1986; 19(2):257-69. PubMed ID: 3470084
[TBL] [Abstract][Full Text] [Related]
5. Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell line.
Embleton MJ; Gunn B; Byers VS; Baldwin RW
Br J Cancer; 1981 May; 43(5):582-7. PubMed ID: 6941806
[TBL] [Abstract][Full Text] [Related]
6. [Study of expression of surface antigen p72 using monoclonal antibody 79IT/36 and the effect of ricin A chain-bound 79IT/36 on phytohemagglutinin-stimulated human lymphocytes].
Rytwiński K
Acta Haematol Pol; 1989; 20(1):47-57. PubMed ID: 2618566
[TBL] [Abstract][Full Text] [Related]
7. Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
Price MR; Pimm MV; Baldwin RW
Br J Cancer; 1982 Oct; 46(4):601-10. PubMed ID: 6958308
[TBL] [Abstract][Full Text] [Related]
8. Localization of anti-osteogenic sarcoma monoclonal antibody 791T/36 in a primary human osteogenic sarcoma and its subsequent xenograft in immunodeprived mice.
Pimm MV; Perkins AC; Armitage NC; Baldwin RW
Cancer Immunol Immunother; 1985; 19(1):18-21. PubMed ID: 3856475
[TBL] [Abstract][Full Text] [Related]
9. Analysis of a human osteogenic sarcoma antigen and its expression on various human tumour cell lines.
Campbell DG; Price MR; Baldwin RW
Int J Cancer; 1984 Jul; 34(1):31-7. PubMed ID: 6589212
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation: NK cells activated by interferon-conjugated monoclonal antibody against human osteosarcoma.
Flannery GR; Pelham JM; Gray JD; Baldwin RW
Eur J Cancer Clin Oncol; 1984 Jun; 20(6):791-8. PubMed ID: 6589163
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36.
Pelham JM; Gray JD; Flannery GR; Pimm MV; Baldwin RW
Cancer Immunol Immunother; 1983; 15(3):210-6. PubMed ID: 6577942
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
Affleck K; Embleton MJ
Br J Cancer; 1992 Jun; 65(6):838-44. PubMed ID: 1616855
[TBL] [Abstract][Full Text] [Related]
13. Cross-reaction of 791T/36 monoclonal antibody with immunological activated human peripheral blood mononuclear cells.
Rytwiński K
Arch Immunol Ther Exp (Warsz); 1988; 36(6):679-86. PubMed ID: 3267080
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against osteosarcoma and colon cancer.
Embleton MJ; Brown A; Gunn B; Byers VS; Baldwin RW
Behring Inst Mitt; 1984 May; (74):35-8. PubMed ID: 6591916
[TBL] [Abstract][Full Text] [Related]
15. Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
Embleton MJ; Garnett MC; Jacobs E; Baldwin RW
Br J Cancer; 1984 May; 49(5):559-65. PubMed ID: 6586198
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to human osteosarcoma-associated antigen(s).
Tsang KY; Warren RQ; Bishop L; Pathak S; Koger B; LaVia MF
J Natl Cancer Inst; 1986 Dec; 77(6):1175-80. PubMed ID: 3467110
[TBL] [Abstract][Full Text] [Related]
17. Conjugates of monoclonal antibody 791T/36 with methotrexate in cancer therapy.
Baldwin RW; Embleton MJ; Garnett MC; Pimm MV
NCI Monogr; 1987; (3):95-9. PubMed ID: 3469528
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB
J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627
[TBL] [Abstract][Full Text] [Related]
19. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
Woodhouse CS; Morgan AC
Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.
Young DA; Prout GR; Lin CW
Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
